A detailed history of Walleye Trading LLC transactions in Liquidia Corp stock. As of the latest transaction made, Walleye Trading LLC holds 9,931 shares of LQDA stock, worth $109,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,931
Previous 22,400 55.67%
Holding current value
$109,340
Previous $330,000 63.94%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$11.96 - $15.71 $1.05 Million - $1.38 Million
-87,730 Reduced 89.83%
9,931 $119,000
Q1 2024

May 15, 2024

SELL
$11.35 - $16.73 $1.07 Million - $1.58 Million
-94,337 Reduced 49.13%
97,661 $1.44 Million
Q4 2023

Feb 14, 2024

BUY
$5.77 - $12.19 $943,493 - $1.99 Million
163,517 Added 574.13%
191,998 $2.31 Million
Q3 2023

Nov 14, 2023

BUY
$6.27 - $8.15 $178,575 - $232,120
28,481 New
28,481 $180,000
Q1 2023

May 15, 2023

BUY
$5.72 - $7.91 $100,574 - $139,081
17,583 New
17,583 $121,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.